1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Human Insulin Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Indication (Type I Diabetes, Type II Diabetes)
5.2.2. By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N)
5.2.3. By Route of Administration (Subcutaneous, Transdermal, Nasal, Intravenous, Oral and Others)
5.2.4. By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
5.2.5. By Onset Time (Rapid acting, Short-acting, Intermediate acting, Long acting, Pre-Mixed, Inhaled, Ultra-long Acting)
5.2.6. By Products (Insulin Pens, Insulin Pumps, Infusion System, Injections)
5.2.7. By Region
5.2.8. By Company (2025)
5.3. Market Map
6. North America Human Insulin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Indication
6.2.2. By Brand
6.2.3. By Route of Administration
6.2.4. By Type
6.2.5. By Onset Time
6.2.6. By Products
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1. United States Human Insulin Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Indication
6.3.1.2.2. By Brand
6.3.1.2.3. By Route of Administration
6.3.1.2.4. By Type
6.3.1.2.5. By Onset Time
6.3.1.2.6. By Products
6.3.2. Canada Human Insulin Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Indication
6.3.2.2.2. By Brand
6.3.2.2.3. By Route of Administration
6.3.2.2.4. By Type
6.3.2.2.5. By Onset Time
6.3.2.2.6. By Products
6.3.3. Mexico Human Insulin Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Indication
6.3.3.2.2. By Brand
6.3.3.2.3. By Route of Administration
6.3.3.2.4. By Type
6.3.3.2.5. By Onset Time
6.3.3.2.6. By Products
7. Europe Human Insulin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Brand
7.2.3. By Route of Administration
7.2.4. By Type
7.2.5. By Onset Time
7.2.6. By Products
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Human Insulin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Indication
7.3.1.2.2. By Brand
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Type
7.3.1.2.5. By Onset Time
7.3.1.2.6. By Products
7.3.2. France Human Insulin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Indication
7.3.2.2.2. By Brand
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Type
7.3.2.2.5. By Onset Time
7.3.2.2.6. By Products
7.3.3. United Kingdom Human Insulin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Indication
7.3.3.2.2. By Brand
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Type
7.3.3.2.5. By Onset Time
7.3.3.2.6. By Products
7.3.4. Italy Human Insulin Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Indication
7.3.4.2.2. By Brand
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By Type
7.3.4.2.5. By Onset Time
7.3.4.2.6. By Products
7.3.5. Spain Human Insulin Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Indication
7.3.5.2.2. By Brand
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By Type
7.3.5.2.5. By Onset Time
7.3.5.2.6. By Products
8. Asia Pacific Human Insulin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Brand
8.2.3. By Route of Administration
8.2.4. By Type
8.2.5. By Onset Time
8.2.6. By Products
8.2.7. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Human Insulin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Indication
8.3.1.2.2. By Brand
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Type
8.3.1.2.5. By Onset Time
8.3.1.2.6. By Products
8.3.2. India Human Insulin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Indication
8.3.2.2.2. By Brand
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Type
8.3.2.2.5. By Onset Time
8.3.2.2.6. By Products
8.3.3. Japan Human Insulin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Indication
8.3.3.2.2. By Brand
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Type
8.3.3.2.5. By Onset Time
8.3.3.2.6. By Products
8.3.4. South Korea Human Insulin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Indication
8.3.4.2.2. By Brand
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Type
8.3.4.2.5. By Onset Time
8.3.4.2.6. By Products
8.3.5. Australia Human Insulin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Indication
8.3.5.2.2. By Brand
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Type
8.3.5.2.5. By Onset Time
8.3.5.2.6. By Products
9. Middle East & Africa Human Insulin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Brand
9.2.3. By Route of Administration
9.2.4. By Type
9.2.5. By Onset Time
9.2.6. By Products
9.2.7. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Human Insulin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Indication
9.3.1.2.2. By Brand
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Type
9.3.1.2.5. By Onset Time
9.3.1.2.6. By Products
9.3.2. UAE Human Insulin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Indication
9.3.2.2.2. By Brand
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Type
9.3.2.2.5. By Onset Time
9.3.2.2.6. By Products
9.3.3. South Africa Human Insulin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Indication
9.3.3.2.2. By Brand
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Type
9.3.3.2.5. By Onset Time
9.3.3.2.6. By Products
10. South America Human Insulin Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Brand
10.2.3. By Route of Administration
10.2.4. By Type
10.2.5. By Onset Time
10.2.6. By Products
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Human Insulin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Indication
10.3.1.2.2. By Brand
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Type
10.3.1.2.5. By Onset Time
10.3.1.2.6. By Products
10.3.2. Colombia Human Insulin Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Indication
10.3.2.2.2. By Brand
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Type
10.3.2.2.5. By Onset Time
10.3.2.2.6. By Products
10.3.3. Argentina Human Insulin Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Indication
10.3.3.2.2. By Brand
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Type
10.3.3.2.5. By Onset Time
10.3.3.2.6. By Products
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Human Insulin Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Novo Nordisk A/S
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Eli Lilly and Company
15.3. Sanofi S.A.
15.4. Biocon Limited
15.5. Wockhardt Limited
15.6. Julphar
15.7. Tonghua Dongbao Pharmaceutical Co., Ltd.
15.8. B. Braun Melsungen AG
15.9. Pfizer Inc.
15.10. Ypsomed AG
16. Strategic Recommendations
17. About Us & Disclaimer
Figure 1: Global Human Insulin Market Size,
By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 2: Global Human Insulin Market
Share, By Indication, By Value, 2015-2025F
Figure 3: Global Human Insulin Market Share,
By Brand, By Value, 2015-2025F
Figure 4: Global Human Insulin Market
Share, By Route of Administration, By Value, 2015-2025F
Figure 5: Global Human Insulin Market
Share, By Type, By Value, 2015-2025F
Figure 6: Global Human Insulin Market Share,
By Onset Time, By Value, 2015-2025F
Figure 7: Global Human Insulin Market
Share, By Products, By Value, 2015-2025F
Figure 8: Global Human Insulin Market
Share, By Company, By Value, 2019
Figure 9: Global Human Insulin Market
Share, By Region, By Value, 2015-2025F
Figure 10: Global Human Insulin Market
Share, By Region, By Value, 2015-2025F
Figure 11: Global Human Insulin Market Map,
By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 12: Global Human Insulin Market Map,
By Onset Time, Market Size (USD Billion) & Growth Rate (%)
Figure 13: Global Human Insulin Market Map,
By Products, Market Size (USD Billion) & Growth Rate (%)
Figure 14: Global Human Insulin Market Map,
By Region, Market Size (USD Billion) & Growth Rate (%)
Figure 15: North America Human Insulin
Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 16: North America Human Insulin
Market Share, By Indication, By Value, 2015-2025F
Figure 17: North America Human Insulin
Market Share, By Brand, By Value, 2015-2025F
Figure 18: North America Human Insulin
Market Share, By Route of Administration, By Value, 2015-2025F
Figure 19: North America Human Insulin
Market Share, By Type, By Value, 2015-2025F
Figure 20: North America Human Insulin
Market Share, By Onset Time, By Value, 2015-2025F
Figure 21: North America Human Insulin
Market Share, By Products, By Value, 2015-2025F
Figure 22: North America Human Insulin
Market Share, By Country, By Value, 2015-2025F
Figure 23: North America Human Insulin
Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
Figure 24: United States Human Insulin
Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 25: Total Number of Diabetes
patients in United States, By Value (Millions), 2019, 2030, 2045
Figure 26: United States Human Insulin
Market Share, By Indication, By Value, 2015-2025F
Figure 27: United States Human Insulin
Market Share, By Brand, By Value, 2015-2025F
Figure 28: United States Human Insulin
Market Share, By Route of Administration, By Value, 2015-2025F
Figure 29: United States Human Insulin Market Share, By
Type, By Value, 2015-2025F
Figure 30: United States Human Insulin
Market Share, By Onset Time, By Value, 2015-2025F
Figure 31: United States Human Insulin
Market Share, By Products, By Value, 2015-2025F
Figure 32: Canada Human Insulin Market
Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 33: Total Number of Diabetes
patients in Canada, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 34: Canada Human Insulin Market
Share, By Indication, By Value, 2015-2025F
Figure 35: Canada Human Insulin Market
Share, By Brand, By Value, 2015-2025F
Figure 36: Canada
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 37: Canada Human Insulin Market
Share, By Type, By Value, 2015-2025F
Figure 38: Canada Human Insulin Market
Share, By Onset Time, By Value, 2015-2025F
Figure 39: Canada Human Insulin Market
Share, By Products, By Value, 2015-2025F
Figure 40: Mexico Human Insulin Market
Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
Figure 41: Total Number of Diabetes
patients in Mexico, By Value (Millions), 2019, 2030, 2045
Figure 42: Mexico Human Insulin Market
Share, By Indication, By Value, 2015-2025F
Figure 43: Mexico Human Insulin Market
Share, By Brand, By Value, 2015-2025F
Figure 44: Mexico Human Insulin Market
Share, By Route of Administration, By Value, 2015-2025F
Figure 45: Mexico
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 46: Mexico
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 47: Mexico
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 48: Europe
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 49: Europe
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 50: Europe
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 51: Europe
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 52: Europe
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 53: Europe
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 54: Europe
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 55: Europe
Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 56: Europe
Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate
(%)
Figure 57: Germany
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 58: Germany
undiagnosed and diagnosed diabetes cases, 2019
Figure 59: Germany
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 60: Germany
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 61: Germany
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 62: Germany
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 63: Germany
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 64: Germany
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 65: United
Kingdom Human Insulin Market Size, By Volume (Million Units), By Value (USD
Billion), 2015-2025F
Figure 66: Different
types of diabetes in United Kingdom, 2019
Figure 67: United
Kingdom Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 68: United
Kingdom Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 69: United
Kingdom Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 70: United
Kingdom Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 71: United
Kingdom Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 72: United
Kingdom Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 73: France
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 74: France
Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 75: France
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 76: France
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 77: France
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 78: France
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 79: France
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 80: France
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 81: Italy Human
Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 82: Total
Number of Diabetes patients in Italy, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 83: Italy Human
Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 84: Italy Human
Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 85: Italy Human
Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 86: Italy Human
Insulin Market Share, By Type, By Value, 2015-2025F
Figure 87: Italy Human
Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 88: Italy Human
Insulin Market Share, By Products, By Value, 2015-2025F
Figure 89: Spain Human
Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 90: Total
Number of Diabetes patients in Spain, By Value (1000’s), 2010, 2019, 2030, 2045
Figure 91: Spain Human
Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 92: Spain Human
Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 93: Spain Human
Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 94: Spain Human
Insulin Market Share, By Type, By Value, 2015-2025F
Figure 95: Spain Human
Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 96: Spain Human
Insulin Market Share, By Products, By Value, 2015-2025F
Figure 97: Russia
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 98: Total
Number of Diabetes patients in Russia, By Value (1000’s), 2010, 2019, 2030,
2045
Figure 99: Russia
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 100: Russia
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 101: Russia
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 102: Russia
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 103: Russia
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 104: Russia
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 105: Asia-Pacific
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 106:
Asia-Pacific Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 107:
Asia-Pacific Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 108:
Asia-Pacific Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 109:
Asia-Pacific Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 110:
Asia-Pacific Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 111:
Asia-Pacific Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 112:
Asia-Pacific Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 113:
Asia-Pacific Human Insulin Market Map, By Brand, Market Size (USD Billion)
& Growth Rate (%)
Figure 114: China
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 115: Total
Number of Diabetes patients in China, By Value (Millions), 2019, 2030, 2045
Figure 116: China
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 117: China
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 118: China
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 119: China
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 120: China
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 121: China
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 122: India
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 123: Total
Number of Diabetes patients in India, By Value (Millions), 2019, 2030, 2045
Figure 124: India
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 125: India
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 126: India
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 127: India
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 128: India
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 129: India
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 130: Japan
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 131: Japan
Total Health Expenditure as a share of GDP, 2015 - 2019
Figure 132: Japan
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 133: Japan
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 134: Japan
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 135: Japan
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 136: Japan
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 137: Japan
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 138: South
Korea Human Insulin Market Size, By Volume (Million Units), By Value (USD
Billion), 2015-2025F
Figure 139: Total
Number of Diabetes patients in South Korea, By Value (1000’s), 2010, 2019,
2030, 2045
Figure 140: South
Korea Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 141: South
Korea Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 142: South
Korea Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 143: South
Korea Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 144: South
Korea Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 145: South
Korea Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 146: Australia
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 147: Total
Number of Diabetes patients in Australia, By Value (1000’s), 2010, 2019, 2030,
2045
Figure 148: Australia
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 149: Australia
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 150: Australia
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 151: Australia
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 152: Australia
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 153: Australia
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 154: Singapore
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 155: Total
Number of Diabetes patients in Singapore, By Value (1000’s), 2010, 2019, 2030,
2045
Figure 156: Singapore
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 157: Singapore
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 158: Singapore
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 159: Singapore
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 160: Singapore
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 161: Singapore
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 162: South
America Human Insulin Market Size, By Volume (Million Units), By Value (USD
Billion), 2015-2025F
Figure 163: South
America Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 164: South
America Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 165: South
America Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 166: South
America Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 167: South
America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 168: South
America Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 169: South
America Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 170: South America
Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate
(%)
Figure 171: Brazil
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 172: Total
Number of Diabetes patients in Brazil, By Value (Millions), 2019, 2030, 2045
Figure 173: Brazil
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 174: Brazil
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 175: Brazil
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 176: Brazil
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 177: Brazil
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 178: Brazil
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 179: Argentina
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 180: Argentina
Health Expenditure (% of GDP), 2015-2019
Figure 181: Argentina
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 182: Argentina
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 183: Argentina
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 184: Argentina
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 185: Argentina
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 186: Argentina
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 187: Colombia
Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 188: Total
Number of Diabetes patients in Colombia, By Value (1000’s), 2010, 2019, 2030,
2045
Figure 189: Colombia
Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 190: Colombia
Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 191: Colombia
Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 192: Colombia
Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 193: Colombia
Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 194: Colombia
Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 195: Middle
East and Africa Human Insulin Market Size, By Volume (Million Units), By Value
(USD Billion), 2015-2025F
Figure 196: Middle
East and Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 197: Middle
East and Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 198: Middle
East and Africa Human Insulin Market Share, By Route of Administration, By
Value, 2015-2025F
Figure 199: Middle
East and Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 200: Middle
East and Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 201: Middle
East and Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 202: Middle
East and Africa Human Insulin Market Share, By Country, By Value, 2015-2025F
Figure 203: Middle
East & Africa Human Insulin Market Map, By Brand, Market Size (USD Billion)
& Growth Rate (%)
Figure 204: Saudi
Arabia Human Insulin Market Size, By Volume (Million Units), By Value (USD
Billion), 2015-2025F
Figure 205: Total
Number of Diabetes patients in Saudi Arabia, By Value (1000’s), 2010, 2019,
2030, 2045
Figure 206: Saudi
Arabia Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 207: Saudi
Arabia Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 208: Saudi
Arabia Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 209: Saudi
Arabia Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 210: Saudi
Arabia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 211: Saudi
Arabia Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 212: South
Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD
Billion), 2015-2025F
Figure 213: Total
Number of Diabetes patients in South Africa, By Value (1000’s), 2010, 2019,
2030, 2045
Figure 214: South
Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 215: South
Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 216: South
Africa Human Insulin Market Share, By Route of Administration, By Value,
2015-2025F
Figure 217: South
Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
Figure 218: South
Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 219: South
Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
Figure 220: UAE Human
Insulin Market Size, By Volume (Million Units), By Value (USD Billion),
2015-2025F
Figure 221: UAE Health
Expenditure (% of GDP), 2015-2019
Figure 222: UAE Human
Insulin Market Share, By Indication, By Value, 2015-2025F
Figure 223: UAE Human
Insulin Market Share, By Brand, By Value, 2015-2025F
Figure 224: UAE Human
Insulin Market Share, By Route of Administration, By Value, 2015-2025F
Figure 225: UAE Human
Insulin Market Share, By Type, By Value, 2015-2025F
Figure 226: UAE Human
Insulin Market Share, By Onset Time, By Value, 2015-2025F
Figure 227: UAE Human Insulin Market Share, By
Products, By Value, 2015-2025F